Cargando…

Use of Clozapine for Borderline Personality Disorder: A Case Report

Patients with borderline personality disorder (BPD) show significant impairment in functioning, particularly in the interpersonal and social domains. Prior reports suggest that clozapine may be effective in the management of BPD. We present the case of a patient with BPD who experienced persistent s...

Descripción completa

Detalles Bibliográficos
Autores principales: Amamou, Badii, Salah, Walid Bel Hadj, Mhalla, Ahmed, Benzarti, Nejla, Elloumi, Hend, Zaafrane, Ferid, Gaha, Lotfi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857858/
https://www.ncbi.nlm.nih.gov/pubmed/27121437
http://dx.doi.org/10.9758/cpn.2016.14.2.226
_version_ 1782430708001669120
author Amamou, Badii
Salah, Walid Bel Hadj
Mhalla, Ahmed
Benzarti, Nejla
Elloumi, Hend
Zaafrane, Ferid
Gaha, Lotfi
author_facet Amamou, Badii
Salah, Walid Bel Hadj
Mhalla, Ahmed
Benzarti, Nejla
Elloumi, Hend
Zaafrane, Ferid
Gaha, Lotfi
author_sort Amamou, Badii
collection PubMed
description Patients with borderline personality disorder (BPD) show significant impairment in functioning, particularly in the interpersonal and social domains. Prior reports suggest that clozapine may be effective in the management of BPD. We present the case of a patient with BPD who experienced persistent suicidal ideation and was treated with clozapine at a state psychiatric hospital. After treatment failure with other psychotropic medications, clozapine medication was initiated; not only did suicidal ideation cease, but social and professional functioning also greatly improved to the point of no longer requiring intensive levels of observation or restrictive procedures. Clozapine appears to be efficacious in the management of suicide attempts and self-injurious behavior. Moreover, it appears to be promising as a therapeutic measure for ameliorating the global functioning of patients with severe BPD. Larger, randomized, blinded, and controlled prospective studies are needed to confirm these findings and to determine optimal dosage.
format Online
Article
Text
id pubmed-4857858
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-48578582016-05-06 Use of Clozapine for Borderline Personality Disorder: A Case Report Amamou, Badii Salah, Walid Bel Hadj Mhalla, Ahmed Benzarti, Nejla Elloumi, Hend Zaafrane, Ferid Gaha, Lotfi Clin Psychopharmacol Neurosci Case Report Patients with borderline personality disorder (BPD) show significant impairment in functioning, particularly in the interpersonal and social domains. Prior reports suggest that clozapine may be effective in the management of BPD. We present the case of a patient with BPD who experienced persistent suicidal ideation and was treated with clozapine at a state psychiatric hospital. After treatment failure with other psychotropic medications, clozapine medication was initiated; not only did suicidal ideation cease, but social and professional functioning also greatly improved to the point of no longer requiring intensive levels of observation or restrictive procedures. Clozapine appears to be efficacious in the management of suicide attempts and self-injurious behavior. Moreover, it appears to be promising as a therapeutic measure for ameliorating the global functioning of patients with severe BPD. Larger, randomized, blinded, and controlled prospective studies are needed to confirm these findings and to determine optimal dosage. Korean College of Neuropsychopharmacology 2016-05 2016-05-31 /pmc/articles/PMC4857858/ /pubmed/27121437 http://dx.doi.org/10.9758/cpn.2016.14.2.226 Text en Copyright © 2016, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Amamou, Badii
Salah, Walid Bel Hadj
Mhalla, Ahmed
Benzarti, Nejla
Elloumi, Hend
Zaafrane, Ferid
Gaha, Lotfi
Use of Clozapine for Borderline Personality Disorder: A Case Report
title Use of Clozapine for Borderline Personality Disorder: A Case Report
title_full Use of Clozapine for Borderline Personality Disorder: A Case Report
title_fullStr Use of Clozapine for Borderline Personality Disorder: A Case Report
title_full_unstemmed Use of Clozapine for Borderline Personality Disorder: A Case Report
title_short Use of Clozapine for Borderline Personality Disorder: A Case Report
title_sort use of clozapine for borderline personality disorder: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857858/
https://www.ncbi.nlm.nih.gov/pubmed/27121437
http://dx.doi.org/10.9758/cpn.2016.14.2.226
work_keys_str_mv AT amamoubadii useofclozapineforborderlinepersonalitydisorderacasereport
AT salahwalidbelhadj useofclozapineforborderlinepersonalitydisorderacasereport
AT mhallaahmed useofclozapineforborderlinepersonalitydisorderacasereport
AT benzartinejla useofclozapineforborderlinepersonalitydisorderacasereport
AT elloumihend useofclozapineforborderlinepersonalitydisorderacasereport
AT zaafraneferid useofclozapineforborderlinepersonalitydisorderacasereport
AT gahalotfi useofclozapineforborderlinepersonalitydisorderacasereport